Decision of Shenzhen Securities Regulatory Bureau on ordering jiazhaoye group (Shenzhen) Co., Ltd. to take corrective measures
Shenzhen Securities Regulatory Bureau issued the decision on taking corrective measures against jiazhaoye group (Shenzhen) Co., Ltd.: Shenzhen Securities Regulatory Bureau decided to take corrective regulatory measures against jiazhaoye group (Shenzhen) Co., Ltd. Jiazhaoye group (Shenzhen) Co., Ltd. is required to attach great importance to the above problems, make practical rectification, fulfill the obligation of information disclosure according to law, and submit a written rectification report to the Bureau within 30 days from the date of receiving this decision.
This text is a result of machine translation.
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
In-depth
Briefing Jul 29, 2022 11:42 AM
· Technology
IC Design Company Yuntu Harvests Hundreds of Mns of CNY in Series A+
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Healthcare
Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round
Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.
Yesterday 06:12 PM
Healthcare
Preparation Developer Elite Pharmaceutical Nets Nearly CNY 100 Mn in Series B Round
This financing round will further promote the company's R&D and clinical trials and be used to construct new production bases. The completion of the new production base will significantly improve the application efficiency of the products independently developed by Elite and reduce the cost without reducing the capacity of the products.
Yesterday 05:56 PM
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Healthcare
Aesthetic Medicine Company Tian Shi Wei Nets Tens of Millions of RMB in Series A Round
Soluble microneedle technology has received wide attention from the industry recently and is expected to be commercialized in aesthetic medicine. Tian Shi Wei gained capital preference for its R&D, mass production and quality control capabilities.
Yesterday 04:58 PM
Briefing Jun 28, 2022 03:35 PM
· Healthcare
Bai chongen: it is suggested to use the price mechanism to distribute electricity and distribute the carbon emission quota to end users
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth